Cargando…
Multi-wavelength photoacoustic imaging of inducible tyrosinase reporter gene expression in xenograft tumors
Photoacoustic imaging is an emerging hybrid imaging technology capable of breaking through resolution limits of pure optical imaging technologies imposed by optical-scattering to provide fine-resolution optical contrast information in deep tissues. We demonstrate the ability of multi-wavelength phot...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060505/ https://www.ncbi.nlm.nih.gov/pubmed/24936769 http://dx.doi.org/10.1038/srep05329 |
_version_ | 1782321382501122048 |
---|---|
author | Paproski, Robert J. Heinmiller, Andrew Wachowicz, Keith Zemp, Roger J. |
author_facet | Paproski, Robert J. Heinmiller, Andrew Wachowicz, Keith Zemp, Roger J. |
author_sort | Paproski, Robert J. |
collection | PubMed |
description | Photoacoustic imaging is an emerging hybrid imaging technology capable of breaking through resolution limits of pure optical imaging technologies imposed by optical-scattering to provide fine-resolution optical contrast information in deep tissues. We demonstrate the ability of multi-wavelength photoacoustic imaging to estimate relative gene expression distributions using an inducible expression system and co-register images with hemoglobin oxygen saturation estimates and micro-ultrasound data. Tyrosinase, the rate-limiting enzyme in melanin production, is used as a reporter gene owing to its strong optical absorption and enzymatic amplification mechanism. Tetracycline-inducible melanin expression is turned on via doxycycline treatment in vivo. Serial multi-wavelength imaging reveals very low estimated melanin expression in tumors prior to doxycycline treatment or in tumors with no tyrosinase gene present, but strong signals after melanin induction in tumors tagged with the tyrosinase reporter. The combination of new inducible reporters and high-resolution photoacoustic and micro-ultrasound technology is poised to bring a new dimension to the study of gene expression in vivo. |
format | Online Article Text |
id | pubmed-4060505 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-40605052014-06-18 Multi-wavelength photoacoustic imaging of inducible tyrosinase reporter gene expression in xenograft tumors Paproski, Robert J. Heinmiller, Andrew Wachowicz, Keith Zemp, Roger J. Sci Rep Article Photoacoustic imaging is an emerging hybrid imaging technology capable of breaking through resolution limits of pure optical imaging technologies imposed by optical-scattering to provide fine-resolution optical contrast information in deep tissues. We demonstrate the ability of multi-wavelength photoacoustic imaging to estimate relative gene expression distributions using an inducible expression system and co-register images with hemoglobin oxygen saturation estimates and micro-ultrasound data. Tyrosinase, the rate-limiting enzyme in melanin production, is used as a reporter gene owing to its strong optical absorption and enzymatic amplification mechanism. Tetracycline-inducible melanin expression is turned on via doxycycline treatment in vivo. Serial multi-wavelength imaging reveals very low estimated melanin expression in tumors prior to doxycycline treatment or in tumors with no tyrosinase gene present, but strong signals after melanin induction in tumors tagged with the tyrosinase reporter. The combination of new inducible reporters and high-resolution photoacoustic and micro-ultrasound technology is poised to bring a new dimension to the study of gene expression in vivo. Nature Publishing Group 2014-06-17 /pmc/articles/PMC4060505/ /pubmed/24936769 http://dx.doi.org/10.1038/srep05329 Text en Copyright © 2014, Macmillan Publishers Limited. All rights reserved http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder in order to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Paproski, Robert J. Heinmiller, Andrew Wachowicz, Keith Zemp, Roger J. Multi-wavelength photoacoustic imaging of inducible tyrosinase reporter gene expression in xenograft tumors |
title | Multi-wavelength photoacoustic imaging of inducible tyrosinase reporter gene expression in xenograft tumors |
title_full | Multi-wavelength photoacoustic imaging of inducible tyrosinase reporter gene expression in xenograft tumors |
title_fullStr | Multi-wavelength photoacoustic imaging of inducible tyrosinase reporter gene expression in xenograft tumors |
title_full_unstemmed | Multi-wavelength photoacoustic imaging of inducible tyrosinase reporter gene expression in xenograft tumors |
title_short | Multi-wavelength photoacoustic imaging of inducible tyrosinase reporter gene expression in xenograft tumors |
title_sort | multi-wavelength photoacoustic imaging of inducible tyrosinase reporter gene expression in xenograft tumors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060505/ https://www.ncbi.nlm.nih.gov/pubmed/24936769 http://dx.doi.org/10.1038/srep05329 |
work_keys_str_mv | AT paproskirobertj multiwavelengthphotoacousticimagingofinducibletyrosinasereportergeneexpressioninxenografttumors AT heinmillerandrew multiwavelengthphotoacousticimagingofinducibletyrosinasereportergeneexpressioninxenografttumors AT wachowiczkeith multiwavelengthphotoacousticimagingofinducibletyrosinasereportergeneexpressioninxenografttumors AT zemprogerj multiwavelengthphotoacousticimagingofinducibletyrosinasereportergeneexpressioninxenografttumors |